Dr. Batlevi on Challenges Faced in Follicular Lymphoma Management


In Partnership With:

Connie L. Batlevi, MD, PhD, discusses challenges faced in the treatment of patients with follicular lymphoma.

Connie L. Batlevi, MD, PhD, a medical oncologist specializing in lymphoma at Memorial Sloan Kettering Cancer Center, discusses challenges faced in the treatment of patients with follicular lymphoma.

The lifetime of a patient with follicular lymphoma spans several decades, during which they may require intermittent treatment, says Batlevi. One of the challenges with this disease is determining which treatment can extend disease-free interval for the longest period of time while allowing patients to remain functional; this should be an individualized decision made with the patient, says Batlevi.

Other times, as a patient matures, they acquire different comorbidities and other health issues that are more prominent. In these instances, a physician might have to consider how to manage the disease at the same time as other medical conditions, some of which can be more significant than the follicular lymphoma itself, concludes Batlevi.

Related Videos
Jaime R. Merchán, MD, Sylvester Comprehensive Cancer Center
Rona Yaeger, MD
Mitchell S. Cairo, MD, and Sergio Giralt, MD, experts on veno-occlusive disease
Jeremy L. Ramdial, MD, assistant professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Alexandra Gomez Arteaga, MD, Weill Cornell Medicine/New York-Presbyterian Hospital
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Alice Bertaina, MD, PhD
Jeffery Auletta, MD, The Ohio State University College of Medicine
Betty Hamilton, MD, Cleveland Clinic
Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Center